Oxidative stress and hepatitis C virus

Virology Journal

Volumn 10, Issue 1, 2013, Pages

  Paracha, Usman Zafar ^a   Fatima, Kaneez ^b   Alqahtani, Mohammad ^c   Chaudhary, Adeel ^c   Abuzenadah, Adel ^c   Damanhouri, Ghazi ^c   Qadri, Ishtiaq ^c  

^a Hajvery University   (Pakistan)

^b IQ Institute of Infection and Immunity   (Pakistan)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

HCV; Oxidative stress; ROS

Indexed keywords

COMPLEMENT FACTOR H; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLYCOPROTEIN E1; GLYCOPROTEIN E2; HEME OXYGENASE 1; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5A; NUCLEOCAPSID PROTEIN; PROHIBITIN; REACTIVE OXYGEN METABOLITE; SIRTUIN 6; STAT3 PROTEIN; THIOREDOXIN; TRANSCRIPTION FACTOR NRF2;

ARTICLE; CHRONIC HEPATITIS C; DISEASE SEVERITY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; ENDOPLASMIC RETICULUM; HEPATITIS C VIRUS; HIGH RISK PATIENT; HUMAN; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; VIRUS ENTRY; VIRUS REPLICATION; HEPACIVIRUS; HOST PATHOGEN INTERACTION; LIVER; METABOLISM; PATHOLOGY; PHYSIOLOGY; TOXICITY; VIROLOGY;

HEPATITIS C VIRUS;

HEPACIVIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84881047032     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-251     Document Type: Article

References (92)

1. Qadri I, Iwahashi M, Capasso JM, Hopken MW, Flores S, Schaack J, Simon FR: Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1. Biochem J 2004, 378(Pt 3):919-928.
2. Jones DP: Redefining oxidative stress. Antioxid Redox Signal 2006, 8(9-10):1865-1879.
3. Gloire G, Legrand-Poels S, Piette J: NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 2006, 72(11):1493-1505.
4. Lander HM: An essential role for free radicals and derived species in signal transduction. FASEB J 1997, 11(2):118-124.
5. Devadas S, Zaritskaya L, Rhee SG, Oberley L, Williams MS: Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J Exp Med 2002, 195(1):59-70.
6. Hildeman DA: Regulation of T-cell apoptosis by reactive oxygen species. Free Radic Biol Med 2004, 36(12):1496-1504.
7. Sen CK, Sies H, Baeuerle PA: Antioxidant and redox regulation of genes. Academic Press 2000.
8. Mittler R, Vanderauwera S, Suzuki N, Miller G, Tognetti VB, Vandepoele K, Gollery M, Shulaev V, Van Breusegem F: ROS signaling: the new wave? Trends Plant Sci 2011, 16(6):300-309.
9. Go YM, Jones DP: Redox compartmentalization in eukaryotic cells. Biochim Biophys Acta 2008, 1780(11):1273-1290.
10. Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, Choi AM: Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 2007, 9(1):49-89.
11. Desikan R, Hancock J, Neill S: Reactive Oxygen Species as Signalling Molecules. In Antioxidants and Reactive Oxygen Species in Plants. Oxford, UK: Blackwell Publishing Ltd; 2007:169-196.
12. Yamada S, Nomoto S, Fujii T, Kaneko T, Takeda S, Inoue S, Kanazumi N, Nakao A: Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma. Eur J Surg Oncol 2006, 32(3):303-307.
13. Yen HH, Shih KL, Lin TT, Su WW, Soon MS, Liu CS: Decreased mitochondrial deoxyribonucleic acid and increased oxidative damage in chronic hepatitis C. World J Gastroenterol 2012, 18(36):5084-5089.
14. Okochi O, Hibi K, Uemura T, Inoue S, Takeda S, Kaneko T, Nakao A: Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. Clin Cancer Res 2002, 8(9):2875-2878.
15. Liu CS, Tsai CS, Kuo CL, Chen HW, Lii CK, Ma YS, Wei YH: Oxidative stressrelated alteration of the copy number of mitochondrial DNA in human leukocytes. Free Radic Res 2003, 37(12):1307-1317.
16. Kim JY, Hwang JM, Ko HS, Seong MW, Park BJ, Park SS: Mitochondrial DNA content is decreased in autosomal dominant optic atrophy. Neurology 2005, 64(6):966-972.
17. De Mendoza C, Soriano V: The role of hepatitis C virus (HCV) in mitochondrial DNA damage in HIV/HCV-coinfected individuals. Antivir Ther 2005, 10(Suppl 2):M109-M115.
18. Fujinaga H, Tsutsumi T, Yotsuyanagi H, Moriya K, Koike K: Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species. Oncology 2011, 81(Suppl 1):11-17.
19. Malhotra JD, Kaufman RJ: Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal 2007, 9(12):2277-2293.
20. Berridge MJ, Bootman MD, Roderick HL: Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003, 4(7):517-529.
21. Görlach A, Klappa P, Kietzmann T: The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid Redox Signal 2006, 8(9-10):1391-1418.
22. Lizák B, Czegle I, Csala M, Benedetti A, Mandl J, Bánhegyi G: Translocon pores in the endoplasmic reticulum are permeable to small anions. Am J Physiol Cell Physiol 2006, 291(3):C511-C517.
23. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244(4902):359-362.
24. Simmonds P: Genetic diversity and evolution of hepatitis C virus--15 years on. J Gen Virol 2004, 85(Pt11):3173-3188.
25. WHO: Hepatitis C. http://www.who.int/mediacentre/factsheets/fs164/en/.
26. Ivanov AV, Bartosch B, Smirnova OA, Isaguliants MG, Kochetkov SN: HCV and Oxidative Stress in the Liver. Viruses 2013, 5(2):439-469.
27. Bhargava A, Raghuram GV, Pathak N, Varshney S, Jatawa SK, Jain D, Mishra PK: Occult hepatitis C virus elicits mitochondrial oxidative stress in lymphocytes and triggers PI3-kinase-mediated DNA damage response. Free Radic Biol Med 2011, 51(9):1806-1814.
28. Muriel P: Role of free radicals in liver diseases. Hepatol Int 2009, 3(4):526-536.
29. García-Monzón C, Majano PL, Zubia I, Sanz P, Apolinario A, Moreno-Otero R: Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J Hepatol 2000, 32(2):331-338.
30. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R: Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 1995, 22(4):449-456.
31. Rosen HR, Gretch DR: Hepatitis C virus: current understanding and prospects for future therapies. Mol Med Today 1999, 5(9):393-399.
32. Valgimigli M, Valgimigli L, Trerè D, Gaiani S, Pedulli GF, Gramantieri L, Bolondi L: Oxidative stress EPR measurement in human liver by radicalprobe technique. Correlation with etiology, histology and cell proliferation. Free Radic Res 2002, 36(9):939-948.
33. Valgimigli L, Valgimigli M, Gaiani S, Pedulli GF, Bolondi L: Measurement of oxidative stress in human liver by EPR spin-probe technique. Free Radic Res 2000, 33(2):167-178.
34. Jenny-Avital ER: Hepatitis C. Curr Opin Infect Dis 1998, 11(3):293-299.
35. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, et al: Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 1990, 87(17):6547-6549.
36. Barbaro G, Di Lorenzo G, Asti A, Ribersani M, Belloni G, Grisorio B, Filice G, Barbarini G: Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings. Am J Gastroenterol 1999, 94(8):2198-2205.
37. Forns X, Purcell RH, Bukh J: Quasispecies in viral persistence and pathogenesis of hepatitis C virus. Trends Microbiol 1999, 7(10):402-410.
38. Koike K: Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways. J Gastroenterol Hepatol 2007, 22(Suppl 1):S108-S111.
39. Ivanov AV, Smirnova OA, Ivanova ON, Masalova OV, Kochetkov SN, Isaguliants MG: Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells. PLoS One 2011, 6(9):e24957.
40. Pal S, Polyak SJ, Bano N, Qiu WC, Carithers RL, Shuhart M, Gretch DR, Das A: Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme NEIL1. J Gastroenterol Hepatol 2010, 25(3):627-634.
41. Bureau C, Bernad J, Chaouche N, Orfila C, Béraud M, Gonindard C, Alric L, Vinel JP, Pipy B: Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J Biol Chem 2001, 276(25):23077-23083.
42. García-Mediavilla MV, Sánchez-Campos S, González-Pérez P, Gómez-Gonzalo M, Majano PL, López-Cabrera M, Clemente G, García-Monzón C, González- Gallego J: Differential contribution of hepatitis C virus NS5A and core proteins to the induction of oxidative and nitrosative stress in human hepatocyte-derived cells. J Hepatol 2005, 43(4):606-613.
43. Thorén F, Romero A, Lindh M, Dahlgren C, Hellstrand K: A hepatitis C virusencoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals. J Leukoc Biol 2004, 76(6):1180-1186.
44. Ming-Ju H, Yih-Shou H, Tzy-Yen C, Hui-Ling C: Hepatitis C virus E2 protein induce reactive oxygen species (ROS)-related fibrogenesis in the HSC-T6 hepatic stellate cell line. J Cell Biochem 2011, 112(1):233-243.
45. Li S, Ye L, Yu X, Xu B, Li K, Zhu X, Liu H, Wu X, Kong L: Hepatitis C virus NS4B induces unfolded protein response and endoplasmic reticulum overload response-dependent NF-kappaB activation. Virology 2009, 391(2):257-264.
46. Liang Y, Ye H, Kang CB, Yoon HS: Domain 2 of Nonstructural Protein 5A (NS5A) of Hepatitis C Virus Is Natively Unfolded. Biochemistry 2007, 46(41):11550-11558.
47. Piccoli C, Quarato G, Ripoli M, D'Aprile A, Scrima R, Cela O, Boffoli D, Moradpour D, Capitanio N: Review HCV infection induces mitochondrial bioenergetic unbalance: causes and effects. Biochim Biophys Acta 2009, 1787(5):539-546.
48. Piccoli C, Scrima R, D'Aprile A, Ripoli M, Lecce L, Boffoli D, Capitanio N: Review Mitochondrial dysfunction in hepatitis C virus infection. Biochim Biophys Acta 2006, 1757(9-10):1429-1437.
49. Gong G, Waris G, Tanveer R, Siddiqui A: Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa;B. Proc Natl Acad Sci U S A 2001, 98(17):9599-9604.
50. Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA: Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002, 122(2):366-375.
51. Jaiswal M, LaRusso NF, Shapiro RA, Billiar TR, Gores GJ: Nitric oxidemediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology 2001, 120(1):190-199.
52. Machida K, McNamara G, Cheng KT, Huang J, Wang CH, Comai L, Ou JH, Lai MM: Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1 /Mre11/Rad50 DNA repair pathway in monocytes and hepatocytes. J Immunol 2010, 185(11):6985-6998.
53. Machida K, Tsukamoto H, Liu JC, Han YP, Govindarajan S, Lai MM, Akira S, Ou JH: c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxidedependent impairment of oxidative DNA repair. Hepatology 2010, 52(2):480-492.
54. Zhu Z, Wilson AT, Mathahs MM, Wen F, Brown KE, Luxon BA, Schmidt WN: Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury. Hepatology 2008, 48(5):1430-1439.
55. Sumida Y, Nakashima T, Yoh T, Nakajima Y, Ishikawa H, Mitsuyoshi H, Sakamoto Y, Okanoue T, Kashima K, Nakamura H, Yodoi J: Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J Hepatol 2000, 33(4):616-622.
56. Nakashima T, Sumida Y, Yoh T, Kakisaka Y, Nakajima Y, Ishikawa H, Mitsuyoshi H, Kashima K, Nakamura H, Yodoi J: Thioredoxin levels in the sera of untreated viral hepatitis patients and those treated with glycyrrhizin or ursodeoxycholic acid. Antioxid Redox Signal 2000, 2(4):687-694.
57. Levent G, Ali A, Ahmet A, Polat EC, Aytaç C, Ayse E, Ahmet S: Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy. J Transl Med 2006, 4:25.
58. Osman HG, Gabr OM, Lotfy S, Gabr S: Serum levels of bcl-2 and cellular oxidative stress in patients with viral hepatitis. Indian J Med Microbiol 2007, 25(4):323-329.
59. Tsukiyama-Kohara K: Role of Oxidative Stress in Hepatocarcinogenesis Induced by Hepatitis C Virus. Int J Mol Sci 2012, 13(11):15271-15278.
60. Boudreau HE, Emerson SU, Korzeniowska A, Jendrysik MA, Leto TL: Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV-induced oxidative stress. J Virol 2009, 83(24):12934-12946.
61. Choi J, Ou JH: Review Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol 2006, 290(5):G847-G851.
62. Jain SK, Pemberton PW, Smith A, McMahon RF, Burrows PC, Aboutwerat A, Warnes TW: Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J Hepatol 2002, 36(6):805-811.
63. Weinreb O, Amit T, Mandel S, Kupershmidt L, Youdim MB: Neuroprotective multifunctional iron chelators: from redox-sensitive process to novel therapeutic opportunities. Antioxid Redox Signal 2010, 13(6):919-949.
64. Ganz T, Nemeth E: Hepcidin and iron homeostasis. Biochim Biophys Acta 2012, 1823(9):1434-1443.
65. Andrews NC: Iron homeostasis: insights from genetics and animal models. Nat Rev Genet 2000, 1(3):208-217.
66. Pantopoulos K, Porwal SK, Tartakoff A, Devireddy L: Mechanisms of mammalian iron homeostasis. Biochemistry 2012, 51(29):5705-5724.
67. Riggio O, Montagnese F, Fiore P, Folino S, Giambartolomei S, Gandin C, Merli M, Quinti I, Violante N, Caroli S, Senofonte O, Capocaccia L: Iron overload in patients with chronic viral hepatitis: how common is it? Am J Gastroenterol 1997, 92(8):1298-1301.
68. Kaito M, Iwasa M, Kobayashi Y, Fujita N, Tanaka H, Gabazza EC, Adachi Y, Kojima Y, Nakagawa N, Watanabe S: Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stress in patients with chronic hepatitis C. J Gastroenterol 2006, 41(9):921-922.
69. Fujita N, Horiike S, Sugimoto R, Tanaka H, Iwasa M, Kobayashi Y, Hasegawa K, Ma N, Kawanishi S, Adachi Y, Kaito M: Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients. Free Radic Biol Med 2007, 42(3):353-362.
70. Smirnova OA, Ivanov AV, Ivanova ON, Valuev-Éllison VT, Kochetkov SN: Cellular defense systems against oxidative and ER stresses: mechanisms of regulation and influence of hepatitis C virus. Mol Biol (Mosk) 2011, 45(1):127-141.
71. Aleksunes LM, Manautou JE: Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease. Toxicol Pathol 2007, 35(4):459-473.
72. Yuan L, Kaplowitz N: Glutathione in liver diseases and hepatotoxicity. Mol Aspects Med 2009, 30(1-2):29-41.
73. Morgan B, Ezerina D, Amoako TN, Riemer J, Seedorf M, Dick TP: Multiple glutathione disulfide removal pathways mediate cytosolic redox homeostasis. Nat Chem Biol 2012, 9(2):119-125.
74. Aggarwal A, Misro MM, Maheshwari A, Sehgal N, Nandan D: N-acetylcysteine counteracts oxidative stress and prevents hCG-induced apoptosis in rat Leydig cells through down regulation of caspase-8 and JNK. Mol Reprod Dev 2010, 77(10):900-909.
75. Kerksick C, Willoughby D: The antioxidant role of glutathione and N- acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr 2005, 2:38-44.
76. Pickering AM, Linder RA, Zhang H, Forman HJ, Davies KJ: Nrf2-dependent Induction of Proteasome and Pa28 Regulator Are Required for Adaptation to Oxidative Stress. J Biol Chem 2012, 287(13):10021-10031.
77. Hochmuth CE, Biteau B, Bohmann D, Jasper H: Redox Regulation by Keap1 and Nrf2 Controls Intestinal Stem Cell Proliferation in Drosophila. Cell Stem Cell 2011, 8(2):188-199.
78. Barajas B, Che N, Yin F, Rowshanrad A, Orozco LD, Gong KW, Wang X, Castellani LW, Reue K, Lusis AJ, Araujo JA: NF-E2-Related Factor 2 Promotes Atherosclerosis by Effects on Plasma Lipoproteins and Cholesterol Transport That Overshadow Antioxidant Protection. Arterioscler Thromb Vasc Biol 2011, 31(1):58-66.
79. Burdette D, Olivarez M, Waris G: Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway. J Gen Virol 2010, 91(Pt 3):681-690.
80. Kitada T, Seki S, Iwai S, Yamada T, Sakaguchi H, Wakasa K: In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease. J Hepatol 2001, 35(5):613-618.
81. Carvajal-Yepes M, Himmelsbach K, Schaedler S, Ploen D, Krause J, Ludwig L, Weiss T, Klingel K, Hildt E: Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins. J Biol Chem 2011, 286(11):8941-8951.
82. Weismann D, Hartvigsen K, Lauer N, Bennett KL, Scholl HP, Charbel Issa P, Cano M, Brandstätter H, Tsimikas S, Skerka C, Superti-Furga G, Handa JT, Zipfel PF, Witztum JL, Binder CJ: Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 2011, 478(7367):76-81.
83. Qadri I, Iwahashi M, Kullak-Ublick GA, Simon FR: Hepatocyte nuclear factor (HNF) 1 and HNF4 mediate hepatic multidrug resistance protein 2 upregulation during hepatitis C virus gene expression. Mol Pharmacol 2006, 70(2):627-636.
84. Mao Z, Hine C, Tian X, Van Meter M, Au M, Vaidya A, Seluanov A, Gorbunova V: SIRT6 Promotes DNA Repair Under Stress by Activating PARP1. Science 2011, 332(6036):1443-1446.
85. Berkson BM: A conservative triple antioxidant approach to the treatment of hepatitis C. Combination of alpha lipoic acid (thioctic acid), silymarin, and selenium: three case histories. Med Klin (Munich) 1999, 94:84-89.
86. Bilska A, Wlodek L: Lipoic acid - the drug of the future? Pharmacol Rep 2005, 57(5):570-577.
87. Syed GH, Siddiqui A: Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus. Hepatology 2011, 54(6):1936-1946.
88. Emerit J, Samuel D, Pavio N: Cu-Zn super oxide dismutase as a potential antifibrotic drug for hepatitis C related fibrosis. Biomed Pharmacother 2006, 60(1):1-4.
89. Tai DI, Tsai SL, Chen YM, Chuang YL, Peng CY, Sheen IS, Yeh CT, Chang KS, Huang SN, Kuo GC, Liaw YF: Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 2000, 31(3):656-664.
90. Gane EJ, Weilert F, Orr DW, Keogh GF, Gibson M, Lockhart MM, Frampton CM, Taylor KM, Smith RA, Murphy MP: The mitochondria-targeted antioxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int 2010, 30(7):1019-1026.
91. Bartosch B: HCV and Liver Carbohydrate Metabolism. In 7th Annual Meeting the New Visby University Network on Hepatitis C, Tartu, Estonia: February 20-23, 2010. Edited by Isaguliants MG. 2010.
92. Marcus NY, Blomenkamp K, Ahmad M, Teckman JH: Oxidative stress contributes to liver damage in a murine model of alpha-1-antitrypsin deficiency. Exp Biol Med (Maywood) 2012, 237(10):1163-1172.